The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes

Objective There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamour, Daniella, Vafadari, Nika, Clayton, Lisa M, Solano, Joshua J, Hughes, Patrick G, Shih, Richard D, Alter, Scott M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580605/
https://www.ncbi.nlm.nih.gov/pubmed/36277574
http://dx.doi.org/10.7759/cureus.29247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580605/
https://www.ncbi.nlm.nih.gov/pubmed/36277574
http://dx.doi.org/10.7759/cureus.29247

Ejemplares similares